首页> 外文期刊>Journal of the American Chemical Society >In Vitro Selection of a DNA-Templated Small-Molecule Library Reveals a Class of Macrocyclic Kinase Inhibitors
【24h】

In Vitro Selection of a DNA-Templated Small-Molecule Library Reveals a Class of Macrocyclic Kinase Inhibitors

机译:DNA模板的小分子文库的体外选择揭示了一类大环激酶抑制剂。

获取原文
获取原文并翻译 | 示例
       

摘要

DNA-templated organic synthesis enables the translation of DNA sequences into synthetic small-molecule libraries suitable for in vitro selection. Previously, we described the DNA-templated multistep synthesis of a 13 824-membered small-molecule macrocycle library. Here, we report the discovery of small molecules that modulate the activity of kinase enzymes through the in vitro selection of this DNA-templated small-molecule macrocycle library against 36 biomedically relevant protein targets. DNA encoding selection survivors was amplified by PCR and identified by ultra-high-throughput DNA sequencing. Macrocycles corresponding to DNA sequences enriched upon selection against several protein kinases were synthesized on a multimilligram scale. In vitro assays revealed that these macrocycles inhibit (or activate) the kinases against which they were selected with IC_(50) values as low as 680 nM. We characterized in depth a family of macrocycles enriched upon selection against Src kinase, and showed that inhibition was highly dependent on the identity of macrocycle building blocks as well as on backbone conformation. Two macrocycles in this family exhibited unusually strong Src inhibition selectivity even among kinases closely related to Src. One macrocycle was found to activate, rather than inhibit, its target kinase, VEGFR2. Taken together, these results establish the use of DNA-templated synthesis and in vitro selection to discover small molecules that modulate enzyme activities, and also reveal a new scaffold for selective ATP-competitive kinase inhibition.
机译:以DNA为模板的有机合成可将DNA序列翻译成适合体外选择的合成小分子文库。以前,我们描述了13 824元小分子大环文库的DNA模板多步合成。在这里,我们报告了通过体外选择针对36种生物医学相关蛋白质靶标的DNA模板化小分子大分子文库来调节激酶活性的小分子的发现。通过PCR扩增编码选择幸存者的DNA,并通过超高通量DNA测序进行鉴定。以数毫克规模合成对应于针对几种蛋白激酶进行选择后富集的DNA序列的大环。体外试验表明,这些大环化合物抑制(或激活)针对其选择的激酶,其IC_(50)值低至680 nM。我们深入表征了对Src激酶进行选择后富集的大环家族,并显示抑制作用高度依赖于大环构建基块的身份以及骨架构象。该家族中的两个大环即使在与Src密切相关的激酶之间也显示出异常强的Src抑制选择性。发现一个大环激活而不是抑制其靶激酶VEGFR2。综上所述,这些结果确立了使用DNA模板合成和体外选择来发现可调节酶活性的小分子的方法,并且还揭示了一种选择性ATP竞争性激酶抑制的新支架。

著录项

  • 来源
    《Journal of the American Chemical Society》 |2010年第33期|p.11779-11791|共13页
  • 作者单位

    Department of Chemistry and Chemical Biology and the Howard Hughes Medical Institute,Harvard University, 12 Oxford Street, Cambridge, Massachusetts 02138;

    rnDepartment of Chemistry and Chemical Biology and the Howard Hughes Medical Institute,Harvard University, 12 Oxford Street, Cambridge, Massachusetts 02138;

    rnDepartment of Chemistry and Chemical Biology and the Howard Hughes Medical Institute,Harvard University, 12 Oxford Street, Cambridge, Massachusetts 02138;

    rnDepartment of Chemistry and Chemical Biology and the Howard Hughes Medical Institute,Harvard University, 12 Oxford Street, Cambridge, Massachusetts 02138;

    rnDepartment of Chemistry and Chemical Biology and the Howard Hughes Medical Institute,Harvard University, 12 Oxford Street, Cambridge, Massachusetts 02138;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 03:15:45

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号